Novel Biomarkers in Health and Disease
A Special Issue of Medicina (ISSN 1648-9144).
Deadline for manuscript submissions: 31 March 2027 | Viewed by 341
Editor
2. Laboratory of Reliability and Quality Control in Laboratory Hematology (HemQcR), Department of Bio-Medical Sciences, School of Health & Caring Sciences, University of West Attica (UniWA), 12243 Athens, Greece
Interests: biomarkers; blood cells; red blood cells; immune system; hematology; gene signatures; biosignatures; omics; hemocombatibility; nanomaterials; cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Biomarkers are fundamental to advancing our understanding of human health and disease, providing critical tools for diagnosis, prognosis, disease monitoring, and therapeutic stratification. Rapid progress in omics technologies, including genomics, transcriptomics, proteomics, metabolomics, and single-cell approaches, has enabled the discovery of novel molecular and cellular biomarkers from blood, tissues, and disease microenvironments, offering unprecedented insight into disease mechanisms and immune regulation.
This Special Issue, “Novel Biomarkers in Health and Disease,” aims to collect high-quality original research articles and reviews addressing emerging biomarkers across a broad spectrum of diseases, including cancer, immune-mediated disorders, cardiovascular, metabolic, infectious, and inflammatory diseases. Particular emphasis is placed on proteomic, genetic, gene expression-based, blood-derived, and immune-related biomarkers with translational and clinical relevance.
Topics of interest include, but are not limited to, the following:
- Proteomics and protein-based biomarkers;
- Integrated -omics approaches (genomics, transcriptomics, proteomics, metabolomics);
- Genetic biomarkers, gene variants, and epigenetic markers;
- Gene expression profiling, transcriptomics, and single-cell technologies;
- Circulating blood cells and immune cell subpopulations;
- MicroRNAs, non-coding RNAs, and RNA-based biomarkers;
- Extracellular vesicles, microvesicles, and exosomes as carriers of proteins and nucleic acids;
- Immune signatures, inflammatory pathways, and systems immunology;
- Tumor microenvironment and systemic immune responses;
- Liquid biopsy and minimally invasive biomarker discovery;
- Biomarkers for disease diagnosis, prognosis, and therapeutic response;
- Translational and clinical applications of omics-derived biomarkers.
Both basic, translational, and clinical studies, as well as state-of-the-art reviews, are welcome. Contributions combining multi-omics technologies with immunological and cellular analyses are particularly encouraged.
Dr. Sotirios P. Fortis
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomarkers
- microvesicles
- omics
- health
- disease
- microenvironment
- blood
- immune system
- blood cells
- cancer
- inflammation
- physiology
- pathophysiology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
